[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 118,286
  • Shares Outstanding, K 69,580
  • Annual Sales, $ 149,160 K
  • Annual Income, $ -39,000 K
  • EBIT $ -31 M
  • EBITDA $ -28 M
  • 60-Month Beta 0.87
  • Price/Sales 0.77
  • Price/Cash Flow N/A
  • Price/Book 4.28

Options Overview Details

View History
  • Implied Volatility 161.77% (-19.26%)
  • Historical Volatility 108.70%
  • IV Percentile 31%
  • IV Rank 9.68%
  • IV High 728.52% on 03/13/26
  • IV Low 101.04% on 08/20/25
  • Expected Move (DTE 14) 0.7055 (36.37%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 218
  • Volume Avg (30-Day) 271
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 7,138
  • Open Int (30-Day) 6,703
  • Expected Range 1.2345 to 2.6455

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.17
  • Number of Estimates 1
  • High Estimate $-0.17
  • Low Estimate $-0.17
  • Prior Year $-0.21
  • Growth Rate Est. (year over year) +19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2600 +53.97%
on 04/10/26
1.9550 -0.77%
on 04/30/26
+0.6700 (+52.76%)
since 03/30/26
3-Month
0.8000 +142.50%
on 03/17/26
2.1300 -8.92%
on 02/11/26
-0.1500 (-7.18%)
since 01/30/26
52-Week
0.8000 +142.50%
on 03/17/26
4.8495 -60.00%
on 08/05/25
-2.4400 (-55.71%)
since 04/30/25

Most Recent Stories

More News
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...

STIM : 1.9400 (+14.12%)
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve...

STIM : 1.9400 (+14.12%)
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

MALVERN, Pa., April 13, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life...

STIM : 1.9400 (+14.12%)
Neuronetics Comments on Letter from Pointillist Family Office

MALVERN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve...

STIM : 1.9400 (+14.12%)
Neuronetics Announces Chief Financial Officer Transition

MALVERN, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve...

STIM : 1.9400 (+14.12%)
Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business

Delivers Letter to STIM Board Outlining Potential 5-7x Upside for Shareholders Inherent in Sale of TMS and Standalone Clinic Business

STIM : 1.9400 (+14.12%)
Neuronetics: Q4 Earnings Snapshot

Neuronetics: Q4 Earnings Snapshot

STIM : 1.9400 (+14.12%)
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37%...

STIM : 1.9400 (+14.12%)
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve...

STIM : 1.9400 (+14.12%)
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare...

STIM : 1.9400 (+14.12%)

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 2.3117
2nd Resistance Point 2.1333
1st Resistance Point 2.0367
Last Price 1.9400
1st Support Level 1.7617
2nd Support Level 1.5833
3rd Support Level 1.4867

See More

52-Week High 4.8495
Fibonacci 61.8% 3.3026
Fibonacci 50% 2.8248
Fibonacci 38.2% 2.3469
Last Price 1.9400
52-Week Low 0.8000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.